Simulations Plus Common Stock Net 2012-2026 | SLP
Simulations Plus common stock net from 2012 to 2026. Common stock net can be defined as the value of common equity ownership.
|
Simulations Plus Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $145 |
| 2022 | $139 |
| 2021 | $133 |
| 2020 | $129 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
|
Simulations Plus Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-11-30 | $0 |
| 2025-08-31 | $0 |
| 2025-05-31 | $20 |
| 2025-02-28 | $156 |
| 2024-11-30 | $154 |
| 2024-08-31 | $0 |
| 2024-05-31 | $150 |
| 2024-02-29 | $148 |
| 2023-11-30 | $147 |
| 2023-08-31 | $145 |
| 2023-05-31 | $144 |
| 2023-02-28 | $138 |
| 2022-11-30 | $140 |
| 2022-08-31 | $139 |
| 2022-05-31 | $138 |
| 2022-02-28 | $135 |
| 2021-11-30 | $135 |
| 2021-08-31 | $133 |
| 2021-05-31 | $132 |
| 2021-02-28 | $131 |
| 2020-11-30 | $129 |
| 2020-08-31 | $129 |
| 2020-05-31 | $0 |
| 2020-02-29 | $0 |
| 2019-11-30 | $0 |
| 2019-08-31 | $0 |
| 2019-05-31 | $0 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | $0 |
| 2018-05-31 | $0 |
| 2018-02-28 | $0 |
| 2017-11-30 | $0 |
| 2017-08-31 | $0 |
| 2017-05-31 | $0 |
| 2017-02-28 | $0 |
| 2016-11-30 | $0 |
| 2016-08-31 | $0 |
| 2016-05-31 | $0 |
| 2016-02-29 | $0 |
| 2015-11-30 | $0 |
| 2015-08-31 | $0 |
| 2015-05-31 | $0 |
| 2015-02-28 | $0 |
| 2014-11-30 | $0 |
| 2014-08-31 | $0 |
| 2014-05-31 | $0 |
| 2014-02-28 | $0 |
| 2013-11-30 | $0 |
| 2013-08-31 | $0 |
| 2013-05-31 | $0 |
| 2013-02-28 | $0 |
| 2012-11-30 | $0 |
| 2012-08-31 | $0 |
| 2012-05-31 | $0 |
| 2012-02-29 | $0 |
| 2011-11-30 | $0 |
| 2011-08-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Computer Software | $0.263B | $0.079B |
| Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microsoft (MSFT) | United States | $2753.943B | 24.11 |
| Oracle (ORCL) | United States | $397.153B | 23.29 |
| SAP SE (SAP) | Germany | $200.369B | 23.43 |
| Intuit (INTU) | United States | $97.052B | 20.83 |
| Adobe (ADBE) | United States | $91.086B | 12.68 |
| Synopsys (SNPS) | United States | $75.138B | 41.38 |
| Cadence Design Systems (CDNS) | United States | $73.347B | 48.30 |
| Dassault Systemes SA (DASTY) | France | $26.551B | 15.11 |
| SS&C Technologies Holdings (SSNC) | United States | $16.192B | 12.48 |
| PTC (PTC) | United States | $15.879B | 17.91 |
| Manhattan Associates (MANH) | United States | $7.161B | 34.05 |
| Pegasystems (PEGA) | United States | $6.655B | 28.74 |
| Descartes Systems Group (DSGX) | Canada | $5.426B | 33.91 |
| Open Text (OTEX) | Canada | $5.117B | 5.65 |
| Trend Micro (TMICY) | Japan | $4.192B | 18.33 |
| ACI Worldwide (ACIW) | United States | $4.058B | 17.19 |
| CommVault Systems (CVLT) | United States | $3.908B | 37.98 |
| Sapiens (SPNS) | Israel | $2.433B | 31.04 |
| Blackbaud (BLKB) | United States | $1.574B | 12.02 |
| PROS Holdings (PRO) | United States | $1.123B | 0.00 |
| Progress Software (PRGS) | United States | $1.121B | 5.56 |
| Rand Worldwide (RWWI) | United States | $0.506B | 0.00 |
| OptimizeRx (OPRX) | United States | $0.115B | 9.15 |
| NetSol Technologies (NTWK) | United States | $0.040B | 21.06 |
| Neonode (NEON) | Sweden | $0.024B | 0.00 |
| Smith Micro Software (SMSI) | United States | $0.018B | 0.00 |
| Wetouch Technology (WETH) | China | $0.016B | 2.21 |
| Global Interactive Technologies (GITS) | South Korea | $0.009B | 0.00 |
| Magic Software Enterprises (MGIC) | Israel | $0.000B | 18.90 |